CHU Heling  

  • Graduate Supervisor, Associate Researcher, Associate Chief Physician
  • Department: Geriatrics
  • Research Area: Geriatrics
  • Research Interests: Cognitive impairment, Cerebrovascular Diseases
  • Contact: chuheling85@163.com
  • Associate Chief Physician, Associate Researcher, Department of Geriatrics, Shanghai Sixth People’s Hospital, 2021-present
  • Resident Physician, Attending Physician, Department of Neurology, Huashan Hospital, Fudan University, 2012-2021
  • MD from Fudan University, 2004-2012
  • Managing Director, China Medical Association of Minorities Surgical Branch
  • Committee Member, Chinese Society of Microcirculation Neuroprotection and Rehabilitation Committee
  • Young Committee Member, Vestibular Disorders Committee of China Medicine Education Association 
  • Committee Member, Chinese Society of Precision Medicine
  • Committee Member, Collateral disease branch of Shanghai Society of Traditional Chinese Medicine
  • Young Director, Shanghai Stroke Association 
  • Associate Editor of Heliyon (IF: 4)
  • Guest Associate Editor of Frontiers in Neurology (IF:3.4)
  • Young Editorial Board Member of Neuroscience Bulletin (IF: 5.6)
  • Database expert of Neural Regeneration Research (IF: 6.1)
  • Review expert of National Natural Science Foundation of China
  • Examiner of National Medical Practitioners Examination
  1. Chu H, Huang C, Zhou Z, Tang Y, Dong Q, Guo Q. Inflammatory score predicts early hematoma expansion and poor outcomes in patients with spontaneous intracerebral hemorrhage. Int J Surg. 2023, 109(3):266-276. (IF: 15.3)
  2. Chu H, Huang C, Miao Y, Ren C, Guan Y, Xie F, Fang Z, Guo Q. The Association of Sleep Characteristics and Plasma Biomarkers of Alzheimer’s disease pathology in Older Cognitively Unimpaired Adults with Higher Amyloid-β Burden. J Neurol. 2023, 270: 3008-3021. (IF: 6)
  3. Chu H, Dong J, Tang Y, Huang C, Guo Q. Connexin 43 Promotes Neurogenesis via Regulating Aquaporin-4 after Cerebral Ischemia. Neurotox Res. 2023, 41(4):349-361. (IF: 3.7)
  4. Wang Y, Huang C, Guo Q, Chu H. Aquaporin-4 and Cognitive Disorders. Aging Dis. 2022, 13 (1): 61-72. (IF: 7.4, corresponding author)
  5. Chu H, Huang C, Tang Y, Dong Q, Guo Q. The stress hyperglycemia ratio predicts early hematoma expansion and poor outcomes in patients with spontaneous intracerebral hemorrhage. Ther Adv Neurol Disord. 2022; 15: 17562864211070681. (IF: 5.9)
  6. Chu H, Gao Z, Huang C, Dong J, Tang Y, Dong Q. The relationship between hematoma expansion induced by hypertension and hyperglycemia and blood-brain barrier disruption and its possible mechanism: role of aquaporin-4 and connexin43. Neurosci Bull. 2020, 36: 1369-1380. (IF: 5.20)
  7. Chu H, Huang C, Dong J, Yang X, Xiang J, Dong Q, Tang Y. Lactate dehydrogenase predicts early hematoma expansion and poor outcomes in intracerebral hemorrhage patients. Transl Stroke Res. 2019, 10: 620-629. (IF: 5.78)
  8. Chu H, Huang C, Gao Z, Dong J, Tang Y, Dong Q. Reduction of Ischemic Brain Edema by Combined use of Paeoniflorin and Astragaloside IV via Down-regulating Connexin 43. Phytother Res. 2017, 31: 1410-1418. (IF: 3.35)
  9. Chu H, Ding H, Tang Y, Dong Q. Erythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4. Lab Invest. 2014, 94(9):1042-53. (IF: 3.68, Cover article)
  10. Chu H, Xiang J, Wu P, Su J, Ding H, Tang Y, Dong Q. The role of aquaporin 4 in apoptosis after intracerebral hemorrhage. J Neuroinflamm. 2014, 11:184. (IF: 5.41)